<DOC>
	<DOCNO>NCT00672867</DOCNO>
	<brief_summary>The purpose study compare safety antiviral activity Clevudine Versus Adefovir dipivoxil patient LC-B .</brief_summary>
	<brief_title>A Pilot Study Evaluate Safety Efficacy Clevudine Adefovir Patients With LC-B</brief_title>
	<detailed_description />
	<mesh_term>Adefovir</mesh_term>
	<mesh_term>Adefovir dipivoxil</mesh_term>
	<mesh_term>Clevudine</mesh_term>
	<criteria>1 . Patient 18 year old . 2 . 5 ≦ ChildPugh score ≦ 12 3 . Patient HBV DNA positive DNA level ≥ 1 x 10 ( 4 ) copies/mL within 30 day baseline . 4 . Patient document HBsAg positive &gt; 6 month . 5 . Patient HBeAg positive negative . 6 . Patient ALT AST level range ＞ 1 x ULN &lt; 15 X ULN 7 . Patient liver cirrhosis diagnose image study within 1 year clinical evidence portal hypertension 8 . Life expectancy least 12 month 9 . Female patient negative urine ( BetaHCG ) pregnancy test take within 14 day start therapy . 10 . Patient able give write informed consent prior study start comply study requirement . 1 . Patient currently receive antiviral , immunomodulatory , cytotoxic corticosteroid therapy . 2 . Previous treatment interferon must end least 6 month prior screen visit . 3 . Patients previously treat clevudine , entecavir , lamivudine , adefovir , telbivudine investigational nucleoside HBV infection . 4 . Patient coinfected HCV , HDV HIV . 5 . Patient clinical evidence hepatocellular carcinoma 6 . Patient alphafetoprotein &gt; 400ng/mL . 7 . Patient Hemoglobin &lt; 8g/dL ( Male ) , 7.5g/dL ( Female ) WBC &lt; 1,500mm3 Neutrophils &lt; 500/mm3 Platelet count &lt; 30,000/mm3 . 8 . Patient pregnant breastfeeding . 9 . Patient unwilling use `` effective '' method contraception study 3 month use study drug cease . 10 . Patient clinically relevant history abuse alcohol drug . 11 . Patient previous liver transplantation 12 . Patient significant immunocompromised , gastrointestinal , renal , hematological , psychiatric , bronchopulmonary , biliary disease exclude asymptomatic GB stone , neurological , cardiac , oncologic ( except HCC ) allergic disease medical illness investigator 's opinion might interfere therapy . 13 . Patient creatinine clearance le 60mL/min estimate follow formula : ( 140age year ) ( body weight [ kg ] ) / ( 72 ) ( serum creatinine [ mg/dL ] ) [ Note : multiply estimate 0.85 woman ]</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
</DOC>